Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MediPharm Labs (LABS) Stock Price & Analysis

LABS Stock Chart & Stats

CA$0.07CA$0.00(0.00%)
At close: 10:33 AM EST
C$0.06C$0.07C$0.0810 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
CAD 0.06 - CAD 0.07
52-Week Range
CAD 0.06 - CAD 0.10
Previous Close
CAD 0.07
Volume
N/A
Average Volume (3M)
118.48K
Market Cap
CAD 27.77M
Enterprise Value
CAD 20.36M
Total Cash (Recent Filing)
CAD 9.85M
Total Debt (Recent Filing)
CAD 421.00K
Price to Earnings (P/E)
―
Beta
0.74
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
-0
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Profitability And Margin Recovery

The combination of a 43% gross margin, lower operating expenses, and a second consecutive quarter of positive adjusted EBITDA indicates meaningful operating improvement. If sustained, this recovery can strengthen earnings quality, support reinvestment, and move the company toward durable profitability.

International Medical Growth

Strong international medical growth, particularly in Germany, is expanding the revenue base beyond Canada and increasing the contribution from regulated markets. Continued geographic expansion and replenishment orders could diversify demand and provide a durable platform for future growth.

Balance Sheet Flexibility

Cash reserves, minimal debt, and owned production assets provide financial flexibility while the business completes its turnaround. This position can help fund regulated-market expansion, absorb operating volatility, and reduce solvency pressure relative to a highly leveraged competitor.

Bears Say

VAC Reimbursement Cut

The 30% Veterans Affairs Canada reimbursement reduction has already reduced Canadian medical revenue and directly pressures channel economics. Unless cost, product mix, or supply actions fully offset the change, this policy shift can constrain revenue quality and margins over the coming quarters.

Unprofitable And Cash-Consuming Business

Despite recent quarterly improvement, the trailing business remains unprofitable and does not yet generate positive operating or free cash flow. Continued cash consumption can limit internally funded growth and make sustained profitability, cash conversion, and liquidity management important execution requirements.

Competition And Regulatory Exposure

Competition and regulatory scrutiny in Germany could pressure pricing and make international growth harder to sustain. Because more than 80% of revenue comes from medical channels and over 50% is international, reimbursement, prescribing, and regulatory changes remain material structural exposures.

MediPharm Labs News

LABS FAQ

What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was C$0.06 and its highest was C$0.10 in the past 12 months.
What is MediPharm Labs’s market cap?
MediPharm Labs’s market cap is C$27.77M.
When is MediPharm Labs’s upcoming earnings report date?
MediPharm Labs’s next earnings report is estimated for Nov 16, 2026 (not yet confirmed), which is in 13 days.
How were MediPharm Labs’s earnings last quarter?
MediPharm Labs released its earnings results on Aug 13, 2026. The company reported C$0 earnings per share for the quarter, beating the consensus estimate of -C$0.003 by C$0.003.
Is MediPharm Labs overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MediPharm Labs pay dividends?
MediPharm Labs does not currently pay dividends.
What is MediPharm Labs’s EPS estimate?
MediPharm Labs’s EPS estimate is -0.00.
How many shares outstanding does MediPharm Labs have?
MediPharm Labs has 427,177,150 shares outstanding.
What happened to MediPharm Labs’s price movement after its last earnings report?
MediPharm Labs reported an EPS of C$0 in its last earnings report, beating expectations of -C$0.003. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of MediPharm Labs?
Currently, no hedge funds are holding shares in TSE:LABS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology